Welcome to our dedicated page for PNTMU news (Ticker: PNTMU), a resource for investors and traders seeking the latest updates and insights on PNTMU stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PNTMU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PNTMU's position in the market.
Pontem Corporation (NYSE: PNTM.U) announced on June 1, 2021 that it received a notice of non-compliance from the NYSE due to delays in filing its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021. The delay is attributed to new SEC guidance issued on April 12, 2021, regarding accounting for warrants issued by SPACs. The company is currently working to file the report as soon as possible.
Pontem Corporation has announced the pricing of its initial public offering (IPO) of 60 million units at $10.00 per unit. The units will trade on the New York Stock Exchange under the ticker symbol PNTM.U starting January 13, 2021. Each unit contains one Class A ordinary share and one-third of a redeemable warrant, which allows for the purchase of one share at $11.50. The offering, closing on January 15, 2021, may increase by an additional 9 million units if the underwriter exercises its over-allotment option. Credit Suisse and Guggenheim are the joint book-running managers for this IPO.
